A randomized controlled clinical trial of recombinant human alpha-2a interferon (IFN) in cryptogenic chronic active liver disease: Preliminary results
2012 ◽
Vol 33
(3)
◽
pp. 593-599
◽
2017 ◽
Vol 44
(2)
◽
pp. 204-214
◽
2018 ◽
Vol 24
◽
pp. 181-182
◽
2018 ◽
Vol 37
(3)
◽
pp. 223-233
◽